Invest1 publisher2 min readPublished
Teucrium's inverse XRP ETF waits 628 days for an effectiveness date
Teucrium's 2x inverse XRP fund is now due to go effective on October 11, 2026, 628 days after its initial registration, and the leveraged long version it mirrors has been trading since April 2025. No reason for the holdup has been stated.
The Investor · Invest desk
What happened
- The Teucrium 2x Short Daily XRP ETF has a new registration effectiveness date of October 11, 2026, after the SEC pushed back approval following a post-effective amendment filed on September 11, 2026.
- Teucrium first submitted the inverse fund's registration on January 21, 2025, and cryptobriefing reports the process has run the better part of two years without a clear stated reason for the holdup.
- Its leveraged long counterpart, XXRP, launched on April 8, 2025 and had accumulated about $151.5 million in assets under management as of September 2026.
- The inverse fund targets twice the inverse of XRP's daily move, so a 3% fall in XRP is built to return roughly 6% before fees.
- Canary Capital's spot XRP ETF, XRPC, listed in November 2025, adding to a roster that already ran to futures and leveraged long exposure.
Compiled by The InvestorSomething wrong?How this is made
Why it matters
- cost The inverse fund produces nothing for Teucrium until it is effective, and the reset pushes that start past the point where the long twin has about 18 months of trading behind it.
- constraint A -2x daily fund cannot be left on as a quarterly hedge, so a manager using it re-decides the position every day and absorbs decay when XRP is choppy.
- decision Until effectiveness, a manager holding spot XRP who wants downside cover either runs it through his own swap line or sells and books the tax.
Thirty days separate the post-effective amendment from the new effectiveness date [1]. Six hundred and twenty-eight days separate that date from the initial registration [2]. Teucrium's leveraged long version, XXRP, began trading 77 days after the short fund's registration was first submitted [3]. By the time the inverse fund is due to go effective, XXRP will have roughly 18 months of trading behind it [4].
The long fund is the side of the pair with a balance sheet. XXRP held about $151.5 million as of September 2026 [6], which works out to roughly $8.9 million of assets gathered for each month it has traded [5]. Cryptobriefing does not give the inverse fund's expense ratio.
The inverse fund would reach its target exposure through derivatives, primarily swaps, without holding XRP directly [7]. Any account with a swap line can already put that position on. The customer is the manager who holds XRP through a spot wrapper and wants short-duration downside cover without selling the underlying and triggering a taxable event. That is how cryptobriefing describes the ordinary institutional use of inverse products [9]. Canary Capital's spot XRP ETF has been listed since November 2025 [8], about eleven months before the inverse fund's current date [6], so that pool of potential hedgers is bigger now than it was at filing.
There are two defensible readings of the twenty months. One is that the wait cost Teucrium little. The plumbing around XRP filled in while the clock ran, with Ripple's SEC case resolved and spot ETFs approved [11], so the product now arrives where the hedgers already are. The other is that a -2x daily fund has a natural holding period of one day. It will not track twice the inverse of XRP over a month or a quarter, and daily rebalancing erodes returns in choppy markets [10]. So the fund has to recruit its assets over and over instead of banking them.
On the record as published, one amendment and one 30-day shift [2] do not establish that the SEC treats inverse leverage differently from leveraged long exposure. Cryptobriefing reports no clear stated reason for the holdup [4] and describes post-effective amendments as a standard procedural step that can reset the review clock [5]. What the sequence does establish is narrower: a launch date for this wrapper is an estimate the issuer's own filing can move by a month, at a month's notice. If October 11 holds and the fund gathers at anything near XXRP's $8.9 million a month [5], the two-year wait was paperwork.
What to watch
- Another post-effective amendment from Listed Funds Trust before October 11 would move the date again.
- Whether the SEC ever states a reason for the twenty-month review of the inverse product.
- XXRP's asset total after September 2026, as the demand signal for the leveraged pair.